Literature DB >> 21103293

The effects of photodynamic therapy in upper-gastrointestinal malignant diseases.

Key Hyeon Kim1, Jong-Jae Park.   

Abstract

Photodynamic therapy (PDT) is a promising new modality that utilizes the combination of a photosensitizing chemical and visible light for the management of various solid malignancies, including gastrointestinal (GI) cancer. PDT has some advantages over chemotherapy in terms of its greater safety and lower toxicity in the treatment of malignant lesions. However, PDT has not been used widely for treating upper GI cancer due to its relatively low cost-effectiveness and anatomical characteristics of the GI system. Nevertheless, PDT may be an effective alternative therapy for early upper-GI cancer patients who are at a high risk of curative surgical resection or systemic chemotherapy. In some clinical studies, PDT for various upper GI cancer showed positiveresults. To improve the efficacy of PDT for upper GI cancer, development of photosensitezer and light delivery system is needed.

Entities:  

Keywords:  Photodynamic therapy; Photosensitizer; Upper-gastrointestinal cancer

Year:  2010        PMID: 21103293      PMCID: PMC2989553          DOI: 10.5009/gnl.2010.4.S1.S39

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  17 in total

Review 1.  Review article: the potential role for photodynamic therapy in the management of upper gastrointestinal disease.

Authors:  H Barr; A J Dix; C Kendall; N Stone
Journal:  Aliment Pharmacol Ther       Date:  2001-03       Impact factor: 8.171

Review 2.  Photodynamic therapy for cancer: principles.

Authors:  Brian C Wilson
Journal:  Can J Gastroenterol       Date:  2002-06       Impact factor: 3.522

Review 3.  Role of photodynamic therapy in the management of gastrointestinal cancer.

Authors:  A K Kubba
Journal:  Digestion       Date:  1999 Jan-Feb       Impact factor: 3.216

4.  Photodynamic ablation of early cancers of the stomach by means of mTHPC and laser irradiation: preliminary clinical experience.

Authors:  C Ell; L Gossner; A May; H T Schneider; E G Hahn; M Stolte; R Sroka
Journal:  Gut       Date:  1998-09       Impact factor: 23.059

5.  Cooperative clinical trial of photodynamic therapy with photofrin II and excimer dye laser for early gastric cancer.

Authors:  S Mimura; Y Ito; T Nagayo; M Ichii; H Kato; H Sakai; K Goto; Y Noguchi; H Tanimura; Y Nagai; S Suzuki; Y Hiki; Y Hayata
Journal:  Lasers Surg Med       Date:  1996       Impact factor: 4.025

6.  Photodynamic ablation of high-grade dysplasia and early cancer in Barrett's esophagus by means of 5-aminolevulinic acid.

Authors:  L Gossner; M Stolte; R Sroka; K Rick; A May; E G Hahn; C Ell
Journal:  Gastroenterology       Date:  1998-03       Impact factor: 22.682

7.  Endoscopic ablation of Barrett's oesophagus: a randomized-controlled trial of photodynamic therapy vs. argon plasma coagulation.

Authors:  C J Kelty; R Ackroyd; N J Brown; T J Stephenson; C J Stoddard; M W R Reed
Journal:  Aliment Pharmacol Ther       Date:  2004-12       Impact factor: 8.171

8.  Photodynamic therapy for dysplastic Barrett's oesophagus: a prospective, double blind, randomised, placebo controlled trial.

Authors:  R Ackroyd; N J Brown; M F Davis; T J Stephenson; S L Marcus; C J Stoddard; A G Johnson; M W Reed
Journal:  Gut       Date:  2000-11       Impact factor: 23.059

9.  5-aminolevulinic acid photodynamic therapy versus argon plasma coagulation for ablation of Barrett's oesophagus: a randomised trial.

Authors:  M Hage; P D Siersema; H van Dekken; E W Steyerberg; J Haringsma; W van de Vrie; T E Grool; R L P van Veen; H J C M Sterenborg; E J Kuipers
Journal:  Gut       Date:  2004-06       Impact factor: 23.059

10.  Hematoporphyrin-derivative and photoradiation therapy of malignant tumors.

Authors:  J S McCaughan; J T Guy; P Hawley; W Hicks; W Inglis; L Laufman; E May; T A Nims; R Sherman
Journal:  Lasers Surg Med       Date:  1983       Impact factor: 4.025

View more
  4 in total

1.  The study of killing effect and inducing apoptosis of 630-nm laser on lung adenocarcinoma A549 cells mediated by hematoporphyrin derivatives in vitro.

Authors:  Cunzhi Lin; Yuanyuan Zhang; Xinhong Zhu; Shichao Cui; Yiwei Cao; Rong Li; Lijun Wang
Journal:  Lasers Med Sci       Date:  2019-05-02       Impact factor: 3.161

Review 2.  Application of photodynamic therapy for liver malignancies.

Authors:  Heng Zou; Fusheng Wang; Jiang-Jiao Zhou; Xi Liu; Qing He; Cong Wang; Yan-Wen Zheng; Yu Wen; Li Xiong
Journal:  J Gastrointest Oncol       Date:  2020-04

Review 3.  Photodynamic therapy in gastroenterology.

Authors:  N Shishkova; O Kuznetsova; T Berezov
Journal:  J Gastrointest Cancer       Date:  2013-09

4.  Antitumor activity of photodynamic therapy performed with nanospheres containing zinc-phthalocyanine.

Authors:  Flávia Arruda Portilho; Cláudio Eduardo de Oliveira Cavalcanti; Ana Luisa Miranda-Vilela; Luciana Landim Carneiro Estevanato; João Paulo Figueiró Longo; Maria de Fátima Menezes Almeida Santos; Anamélia Lorenzetti Bocca; Olímpia Paschoal Martins; Andreza R Simioni; Paulo César Morais; Ricardo Bentes Azevedo; Antonio Claudio Tedesco; Zulmira Guerrero Marques Lacava
Journal:  J Nanobiotechnology       Date:  2013-12-16       Impact factor: 10.435

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.